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TO THE EDITOR
Methylparaben (MP) is used to extend
the shelf-life of industrial chemicals
(Cashman and Warshaw, 2005). How-
ever, when the skin is exposed to MP,
this compound permeates the epidermis
and the dermis and particularly shows
higher permeation compared with other
parabens because of difference in their
lipophilicity (El Hussein et al., 2007). It
exhibits various adverse dermatological
responses, such as allergic reaction,
synergistic cytotoxic effect of UV radi-
ation, and breast cancer development
(Nardelli et al., 2009, Dagher et al.,
2012). Concentrations of MP excee-
ding 4 mg ml1 in industrial products
are known to be harmful (Darbre and
Harvey, 2008; CIR expert panel, 2008).
Although MP persists in the dermis
(El Hussein et al., 2007), little is
known about its side-effects or
molecular mechanism in the dermis.
We investigated the effects of MP on
the growth of normal human dermal
fibroblasts (nHDFs). Although the rate
of nHDF death was not elevated follow-
ing the exposure to less than
0.4 mg ml1 MP, growth repression
occurred (Supplementary Figure S1a
and b). We then determined whether
the growth repression was due to cell
cycle arrest in nHDFs treated with
0–0.4 mg ml1 MP. Supplementary
Figure S1c shows that MP-treated
nHDFs experience G2/M arrest. Gener-
ally, a G2/M arrest leads to cellular
senescence (CS) if DNA damage is not
repaired (Chien et al., 2000; Stark and
Taylor, 2006). Also, in replicative
senescence, large fraction of senescent
cell population is arrested in G2/M
phase by inducing polyploidy (Mao
et al., 2012). Thus, we determined
whether MP-induced G2/M arrest
correlates with CS in nHDFs. When
arrested nHDFs were regrown in fresh
media, a reduction in growth capability
was observed (Figure 1a). We then
measured the percentage of senes-
cence-associated b-galactosidase (SA-
b-gal)-positive cells, showing an
increase in the percentage of SA-b-gal-
positive cells after MP exposure
(Figure 1b). Furthermore, expression of
other CS markers, such as p53,
p21WAF1, and p16INK4A, was ele-
vated in an MP dose-dependent manner
(Supplementary Figure S2). Repeated
MP treatment resulted in the full CS
phenotype (Supplementary Figure S3).
As reactive oxygen species (ROS) are
important inducers of senescence
(Klimova et al., 2009), we determined
whether MP-induced CS is caused by
intracellular ROS. Figure 1c shows that
MP increased intracellular ROS levels
in nHDFs. To elucidate the physiologi-
cal mechanism of MP-induced CS, we
subsequently focused at 0.4 mg ml1
MP. When intracellular ROS were
eliminated using N-acetylcysteine
(NAC), MP-induced CS was reduced
(Figure 1d). As antioxidant imbalances
can increase intracellular ROS
(Weinberg et al., 2010), we found that
mRNA levels of antioxidant enzymes,
GPX1 and SOD1, were significantly
downregulated following the MP treat-
ment in a dose-dependent manner,
whereas SOD2, CAT, and GSR levels
were unaltered (Figure 1e). MP-induced
CS was rescued by GPX1 and SOD1
overexpression (Supplementary Figures
S4a and b), indicating that MP-induced
CS is GPX1 and SOD1 dependent.
Because these genes have an antioxidant
response element (ARE) in their promoter
regions (Dreger et al., 2009), we
confirmed that ARE activity was signi-
ficantly decreased by MP (Figure 1f).
It was reported that AREs provide
binding sites for transcription factors,
such as NRF2 and AP-1 (c-Jun/c-Fos)
(Dreger et al., 2009; Jeyapaul and
Jaiswal, 2000). However, only c-Jun
was specifically downregulated in MP-
treated nHDFs (Figure 1g), indicating
that GPX1 and SOD1 downregulation
was associated with the c-Jun in
MP-treated nHDFs. We confirmed that
MP inhibited the activation of the TPA-
responsive element, a major binding site
for c-Jun (Figure 1h), suggesting that MP
negatively regulates c-Jun expression.
To investigate the role of c-Jun,
we generated constitutively expressed
c-Jun in nHDFs (lenti-c-Jun) using a
lentivirus encoding c-Jun. nHDFs
expressing lenti-c-Jun did not alter the
expression of GPX1 and SOD1 follow-
ing the MP treatment (Figure 1i). In
addition, ROS levels (Figure 1j) and CS
(Figure 1k) were not increased in MP-
treated nHDFs expressing lenti-c-Jun.
c-Jun expression is reduced by the
glucocorticoid receptor (GR) (Barrett
et al., 1996). Hu et al. (2013) showed
that the GR is regulated by parabens in
adipocytes. Therefore, we investigated
whether downregulation of c-Jun levels
by MP was driven by GRa in nHDFs.
First, we showed that GRa was trans-
located following the MP treatment
(Figure 2a), and the GR element was
activated (Figure 2b), suggesting that
MP-dependent c-Jun transrepression is
mediated by GRa. To investigate the
role of GRa in MP-induced senescence,
we performed a SA-b-gal assay follow-
ing the MP treatment in GRa-depleted
nHDFs. GRa knockdown blocked the
MP-induced decrease in c-Jun expres-
sion (Figure 2c and d) and increase in
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Figure 1. MP induces CS through c-Jun-dependent ROS modulation in nHDFs. (a) The growth capability measured by the population doubling time assay was
repressed in the methylparaben (MP) (0, 0.1, 0.2, and 0.4mg ml 1)-treated normal human dermal fibroblasts (nHDFs) in a dose-dependent manner. (b) MP
elevated SA-b-gal staining in nHDFs. Scale bar¼100mm. (c) MP elevated the levels of intracellular reactive oxygen species (ROS) measured by dichlorofluorescein
diacetate (DCF-DA) staining in nHDFs. (d) MP (0.4 mg ml1)-induced cellular senescence (CS) in nHDFs was reduced by treatment with NAC (1 mM). Scale
bar¼ 100mm. (e) Expression of antioxidant enzymes in the MP-treated nHDFs. (f) MP (0.4mg ml 1) repressed the activity of the antioxidant response elements
(AREs) in the antioxidant gene promoter. (g) ARE binding of transcription factors measured using western blotting (left) and quantitative real-time PCR (right). (h) MP
repressed the activity of the TPA-responsive element in the c-Jun promoter. (i) MP-dependent repression of GPX1 and SOD1 levels was restored by overexpression
of c-Jun. (j) MP-induced ROS levels were restored by overexpression of c-Jun. (k) MP (0.4 mg ml1)-induced CS was restored by c-Jun overexpression. nHDFs were
treated with 0–0.4 mg ml1 MP for 48 hours; results represent the mean±SD, and the symbol denotes a significant difference compared with the untreated nHDFs
(*Po0.05) and compared with the MP-treated nHDFs (#Po0.05). Scale bar¼ 100mm.
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intracellular ROS (Figure 2e) and CS
(Figure 2f).
To address whether CS was induced
by MP in vivo, 400 mg ml 1 MP was
topically applied to the mouse dorsal
skin three times per week for 8 weeks.
The application concentration of MP
was determined on the basis of absorp-
tion rate of B1/1,000 in the skin
(Ishiwatari et al., 2007). Figure 2g
(bottom) shows that the topical applica-
tion of MP increased positive SA-b-gal
staining in the skin of mice. CS disrupts
the extracellular matrix (ECM) compo-
nents by regulating collagens and
MMPs, mainly COL1A1 and MMP1
(Coppe et al., 2008). Supplementary
Figure S5 shows that MP decreased
COL1A1 expression and increased
MMP1 expression in nHDFs. Moreover,
Mmp1a mRNA, murine homology of
human MMP1 (Foley and Kuliopulos,
2014), levels increased, whereas those
of Col1a1 decreased in MP-treated
mouse skin compared with the control
skin (Figure 2h). As expected, macro-
scopic photos show that the skin was
dry and pale, and fine wrinkles
were increased (Figure 2g, upper), and
using the three-dimensional surface
topographic analysis an increase in skin
roughness was also observed (Supple-
mentary Figure S6) in MP-treated mice
compared with control mice. These
changes were markedly reduced by
NAC treatment (Figures 2g and h, and
Supplementary Figure S6). However,
legally allowable concentration of MP
(4 mg ml1) did not induce CS in mice
(data not shown).
Overall, these findings demonstrate
that MP induces CS in vitro and
in vivo, via the GR-c-Jun-ROS pathway
(Figure 2i), and MP-induced CS alters
the ECM components. Although the
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Figure 2. MP induces CS and alters ECM components in vitro and in vivo via the GR-c-Jun-ROS pathway. (a) Methylparaben (MP) (4 mg ml1) treatment resulted
in the translocation of the GRa from the cytosol to the nucleus of normal human dermal fibroblasts (nHDFs) . (b) MP increased the transcriptional activity of the GR
element. (c, d) Knockdown of the GRa restored the MP-induced levels of c-Jun mRNA (c) and protein (d) in nHDFs. (e) Knockdown of the GRa blocked the MP-
induced reactive oxygen species (ROS) levels in nHDFs. (f) Knockdown of the GRa reduced the percentage of senescent cells. Scale bar¼100mm. (g) The
macroscopic images of mouse backs were represented (upper), and cellular senescence (CS) assessment of the mice skin was performed using SA-b-gal (blue) and
nuclear fast red, NRF, (red) double staining (bottom) in response to MP (400 mg ml 1) and NAC (1 M). De, dermal layer; Ep, epidermal layer. (h) Mmp1 mRNA
levels increased (left), whereas those of Col1a1 decreased (right) in MP-treated mouse skin compared with the control skin, analyzed using quantitative real-time
PCR. Results are shown as mean±SD of three independent experiments. *Po0.05 compared with vehicle-treated group; #Po0.05 compared with MP-treated
group. (i) The MP-induced CS pathway.
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treatment doses of MP used in this study
seem high compared with industrial
usage limit (CIR expert panel, 2008),
our data provide evidence regarding the
hypothesis that overdosage of MP may
induce alterations in ECM components
by concentrating senescent dermal
fibroblasts in the dermis.
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Confocal Imaging–Guided Laser Ablation of Basal Cell
Carcinomas: An Ex Vivo Study
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TO THE EDITOR
Laser ablation is a promising approach
for minimally invasive removal of
superficial and early nodular basal cell
carcinomas (BCCs; Smucler and Vlk,
2008; Smucler et al., 2012). The skin
can be removed in mm-thin layers in a
well-controlled manner, increasing pre-
servation of the surrounding normal
tissue. However, tissue is vaporized
such that there is none available for
immediate histopathological confirma-
tion. The efficacy tends to be variable
and recurrence rate (8.25%) low
(Smucler and Vlk, 2008), compared
with that reported for Mohs surgery
(2.1–3.5%; Chren et al., 2011; 2013),
excision (3.5–4.2%), and electrodessi-
cation and curettage (1.6–4.9%). Thus,Accepted article preview online 1 September 2014; published online 25 September 2014
Abbreviations: BCC, basal cell carcinoma; RCM, reflectance confocal microscopy
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